WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of ...
Hosted on MSN
FDA to review Moderna flu vaccine amid RSV advances
The U.S. FDA has agreed to review Moderna’s mRNA flu vaccine after initially declining, as next-generation RSV vaccines advance to address evolving viral strains. RSV continues to pose risks for older ...
Add Yahoo as a preferred source to see more of our stories on Google. Moderna met with FDA officials after the agency initially rejected its application for a new mRNA flu vaccine. - Sarah ...
The Bulwark on MSNOpinion
FDA agrees to review Moderna flu vaccine
Andrew Egger and Jonathan Cohn give their takes on the stunning back-and-forth at the FDA over Moderna’s new mRNA flu vaccine ...
In December 2025, Moderna submitted an application to the FDA to approve the first mRNA-based flu vaccine. Catherine Falls Commercial/Moment via Getty Images Ana Santos Rutschman, Villanova University ...
The U.S. Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday.About two weeks ago, the FDA sent Moderna a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results